Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Oct;60(4):630–633. doi: 10.1038/bjc.1989.328

Response of breast carcinoma to endocrine therapy predicted using immunostained pelleted fine needle aspirates.

E Heyderman 1, S R Ebbs 1, S E Larkin 1, B M Brown 1, A M Haines 1, T Bates 1
PMCID: PMC2247119  PMID: 2803937

Abstract

Fine needle aspirates from 82 patients with breast carcinoma were fixed in methacarn, double embedded in agar or gelatin, and then in paraffin wax. Sequential sections were stained with monoclonal antibodies to the oestrogen receptor-related protein P29 (antibody D5), carcinoembryonic antigen (CEA), epithelial membrane antigen (EMA) and cytokeratin (CAM 5.2). Sixty-one of 82 (74%) aspirates provided sections suitable for immunostaining. Twenty-six (43%) were D5 positive, 23 (38%) CEA positive, 59 (97%) EMA positive, and 54 (89%) CAM 5.2 positive. Twenty-six of these patients were treated with some form of endocrine therapy. Twelve (46%) showed positive staining for D5. Eleven (92%) of the 12 D5-positive patients responded or had static disease, and 8% progressed. Of the 14 D5-negative tumours 43% responded or remained static, and 57% progressed. The difference in response between the D5-positive and the D5-negative tumours was significant (P less than 0.05, Fisher's exact test). There was no correlation between staining for CEA, EMA or cytokeratin and response to endocrine therapy.

Full text

PDF
630

Images in this article

631Figure 1
on p.631
631Figure 2
on p.631
631Figure 3
on p.631
631Figure 4
on p.631

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cano A., Coffer A. I., Adatia R., Millis R. R., Rubens R. D., King R. J. Histochemical studies with an estrogen receptor-related protein in human breast tumors. Cancer Res. 1986 Dec;46(12 Pt 1):6475–6480. [PubMed] [Google Scholar]
  2. Cavailles V., Garcia M., Salazar G., Domergue J., Simony J., Pujol H., Rochefort H. Immunodetection of estrogen receptor and 52,000-dalton protein in fine needle aspirates of breast cancer tumors. J Natl Cancer Inst. 1987 Aug;79(2):245–252. [PubMed] [Google Scholar]
  3. Coombes R. C., Powles T. J., Berger U., Wilson P., McClelland R. A., Gazet J. C., Trott P. A., Ford H. T. Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates. Lancet. 1987 Sep 26;2(8561):701–703. doi: 10.1016/s0140-6736(87)91071-3. [DOI] [PubMed] [Google Scholar]
  4. Ellis I. O., Bell J., Todd J. M., Williams M., Dowle C., Robins A. R., Elston C. W., Blamey R. W., Baldwin R. W. Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma. Br J Cancer. 1987 Sep;56(3):295–299. doi: 10.1038/bjc.1987.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Flowers J. L., Burton G. V., Cox E. B., McCarty K. S., Sr, Dent G. A., Geisinger K. R., McCarty K. S., Jr Use of monoclonal antiestrogen receptor antibody to evaluate estrogen receptor content in fine needle aspiration breast biopsies. Ann Surg. 1986 Mar;203(3):250–254. doi: 10.1097/00000658-198603000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gaskell D. J., Hawkins R. A., Sangsterl K., Chetty U., Forrest A. P. Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen. Lancet. 1989 May 13;1(8646):1044–1046. doi: 10.1016/s0140-6736(89)92445-8. [DOI] [PubMed] [Google Scholar]
  7. Giri D. D., Dangerfield V. J., Lonsdale R., Rogers K., Underwood J. C. Immunohistology of oestrogen receptor and D5 antigen in breast cancer: correlation with oestrogen receptor content of adjacent cryostat sections assayed by radioligand binding and enzyme immunoassay. J Clin Pathol. 1987 Jul;40(7):734–740. doi: 10.1136/jcp.40.7.734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hawkins R. A., Sangster K., Tesdale A., Levack P. A., Anderson E. D., Chetty U., Forrest A. P. The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy. Br J Cancer. 1988 Jul;58(1):77–80. doi: 10.1038/bjc.1988.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hayward J. L., Carbone P. P., Heuson J. C., Kumaoka S., Segaloff A., Rubens R. D. Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. Cancer. 1977 Mar;39(3):1289–1294. doi: 10.1002/1097-0142(197703)39:3<1289::aid-cncr2820390340>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  10. Heyderman E., Brown B. M. Preparation of fine needle aspirates for immunocytochemical studies. Lancet. 1986 Aug 30;2(8505):520–521. doi: 10.1016/s0140-6736(86)90394-6. [DOI] [PubMed] [Google Scholar]
  11. Heyderman E. Immunoperoxidase technique in histopathology: applications, methods, and controls. J Clin Pathol. 1979 Oct;32(10):971–978. doi: 10.1136/jcp.32.10.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Heyderman E., Strudley I., Powell G., Richardson T. C., Cordell J. L., Mason D. Y. A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2. Br J Cancer. 1985 Sep;52(3):355–361. doi: 10.1038/bjc.1985.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. King R. J., Coffer A. I., Gilbert J., Lewis K., Nash R., Millis R., Raju S., Taylor R. W. Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium. Cancer Res. 1985 Nov;45(11 Pt 2):5728–5733. [PubMed] [Google Scholar]
  14. King W. J., Greene G. L. Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature. 1984 Feb 23;307(5953):745–747. doi: 10.1038/307745a0. [DOI] [PubMed] [Google Scholar]
  15. Makin C. A., Bobrow L. G., Bodmer W. F. Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol. 1984 Sep;37(9):975–983. doi: 10.1136/jcp.37.9.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pringle J. H., Homer C. E., Warford A., Kendall C. H., Lauder I. In situ hybridization: alkaline phosphatase visualization of biotinylated probes in cryostat and paraffin sections. Histochem J. 1987 Sep;19(9):488–496. doi: 10.1007/BF01675419. [DOI] [PubMed] [Google Scholar]
  17. Sainsbury J. R., Farndon J. R., Needham G. K., Malcolm A. J., Harris A. L. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet. 1987 Jun 20;1(8547):1398–1402. doi: 10.1016/s0140-6736(87)90593-9. [DOI] [PubMed] [Google Scholar]
  18. Shintaku I. P., Said J. W. Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma. Use of DNase pretreatment to enhance sensitivity of the reaction. Am J Clin Pathol. 1987 Feb;87(2):161–167. doi: 10.1093/ajcp/87.2.161. [DOI] [PubMed] [Google Scholar]
  19. Shousha S., Lyssiotis T., Godfrey V. M., Scheuer P. J. Carcinoembryonic antigen in breast-cancer tissue: a useful prognostic indicator. Br Med J. 1979 Mar 24;1(6166):777–779. doi: 10.1136/bmj.1.6166.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Venter D. J., Tuzi N. L., Kumar S., Gullick W. J. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet. 1987 Jul 11;2(8550):69–72. doi: 10.1016/s0140-6736(87)92736-x. [DOI] [PubMed] [Google Scholar]
  21. Walker R. A. Demonstration of carcinoembryonic antigen in human breast carcinomas by the immunoperoxidase technique. J Clin Pathol. 1980 Apr;33(4):356–360. doi: 10.1136/jcp.33.4.356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wilkinson M. J., Howell A., Harris M., Taylor-Papadimitriou J., Swindell R., Sellwood R. A. The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas. Int J Cancer. 1984 Mar 15;33(3):299–304. doi: 10.1002/ijc.2910330304. [DOI] [PubMed] [Google Scholar]
  23. Wittliff J. L. Steroid-hormone receptors in breast cancer. Cancer. 1984 Feb 1;53(3 Suppl):630–643. doi: 10.1002/1097-0142(19840201)53:3+<630::aid-cncr2820531308>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES